Congenital communicating hydrocephalus

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269505OMIM:615219Q03.8
Who is this for?
Show terms as
1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Congenital communicating hydrocephalus is a rare neurological condition present at birth in which cerebrospinal fluid (CSF) accumulates within the ventricles of the brain despite the absence of an obstruction in the ventricular system. In communicating hydrocephalus, CSF can flow freely between the ventricles but is inadequately absorbed at the arachnoid granulations or, less commonly, is overproduced. This leads to progressive enlargement of the ventricles and increased intracranial pressure. The condition primarily affects the central nervous system and can impact brain development if left untreated. Key clinical features include an abnormally enlarged head circumference (macrocephaly) at birth or in early infancy, a bulging fontanelle, irritability, poor feeding, vomiting, downward deviation of the eyes ("sunsetting" sign), and developmental delays. In severe cases, seizures and progressive neurological deterioration may occur. The diagnosis is typically made through prenatal ultrasound or postnatal neuroimaging such as cranial ultrasound, CT, or MRI, which reveal ventriculomegaly without evidence of obstruction. Treatment is primarily surgical. The most common intervention is the placement of a ventriculoperitoneal (VP) shunt, which diverts excess CSF from the brain ventricles to the peritoneal cavity for absorption. Endoscopic third ventriculostomy (ETV) may be considered in select cases, though its efficacy in communicating hydrocephalus is more limited compared to obstructive forms. Long-term outcomes depend on the severity of the condition, the presence of associated brain abnormalities, and the timeliness of treatment. Many patients require lifelong monitoring for shunt complications, including malfunction, infection, or over-drainage. Early intervention can significantly improve neurodevelopmental outcomes, though some degree of cognitive or motor impairment may persist.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Congenital communicating hydrocephalus.

View clinical trials →

No actively recruiting trials found for Congenital communicating hydrocephalus at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Congenital communicating hydrocephalus community →

Specialists

1 foundView all specialists →

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Congenital communicating hydrocephalus.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Congenital communicating hydrocephalusForum →

No community posts yet. Be the first to share your experience with Congenital communicating hydrocephalus.

Start the conversation →

Latest news about Congenital communicating hydrocephalus

No recent news articles for Congenital communicating hydrocephalus.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Congenital communicating hydrocephalus

What is Congenital communicating hydrocephalus?

Congenital communicating hydrocephalus is a rare neurological condition present at birth in which cerebrospinal fluid (CSF) accumulates within the ventricles of the brain despite the absence of an obstruction in the ventricular system. In communicating hydrocephalus, CSF can flow freely between the ventricles but is inadequately absorbed at the arachnoid granulations or, less commonly, is overproduced. This leads to progressive enlargement of the ventricles and increased intracranial pressure. The condition primarily affects the central nervous system and can impact brain development if left u

At what age does Congenital communicating hydrocephalus typically begin?

Typical onset of Congenital communicating hydrocephalus is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Congenital communicating hydrocephalus?

1 specialists and care centers treating Congenital communicating hydrocephalus are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.